The 12th Pink Ribbon Monaco walk, supporting breast cancer prevention and awareness, will take place on Sunday February 11th 2024, at 10:15 am on the Port Hercules in Monaco.
On this date, hundreds of participants will be mobilised in support of breast cancer awareness.
With funds raised, Pink Ribbon Monaco contribute to breast cancer screening study, in Monaco.
The start will be given at 10:15 am and the 5km circuit passing in front of the Palace, the Cathedral, the Oceanographic Museum and the terraces of the Monte-Carlo Casino will allow people of all sporting levels to participate. Children are welcome and free under 13 years old. People using pushchairs or wheelchairs may need to be assisted in some areas. Don’t forget to bring your four-legged friends too!
In partnership with the Monegasque Athletics Federation (F.M.A) and SBM OFFSHORE, the 11th February 2024 will perpetuate a great sporting and charitable tradition in the Principality, which has already been adopted throughout the world. Unlike other sporting events, participants will not have numbers on their bibs, but will write messages of support or tribute to the victims of breast cancer instead. The aim is not to complete the course in record time, but to participate in large numbers in order to give visibility to the cause we support.
The Pink Ribbon Walk is not only an awareness-raising event in terms of the number of participants, but also a moving show of support for women, sisters, daughters, mothers and friends. If a person participates on behalf of a deceased person, the race becomes a tribute to the life and courage of the victim.
A person may also participate in support of a breast cancer patient. It should be noted that many of the participants are themselves patients or survivors in remission.
Because women are not the only victims of breast cancer!
When a woman fights for her life, or loses her battle against the disease, their husband, father, son or brother are victims.
Pink Ribbon’ Monaco also aims to warn the public that this scourge is not an exclusively female disease.